ClinicalTrials.Veeva

Menu

Effect of WBT for CI With Depression

Capital Medical University logo

Capital Medical University

Status

Enrolling

Conditions

Chronic Insomnia
Depression Disorders

Treatments

Behavioral: Sleep Hygiene Education
Behavioral: Well-Being Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06968013
WBT-CI-D-2025

Details and patient eligibility

About

This randomized controlled trial aims to explore the therapeutic effects of Well-Being Therapy (WBT) on patients with Chronic Insomnia accompanied by depressive symptoms.

Full description

According to DSM-IV criteria, approximately 6%-10% of the adult population in industrialized countries suffer from chronic insomnia (CI), characterized by difficulties in initiating or maintaining sleep accompanied by daytime symptoms persisting for at least four weeks. Chronic insomnia often leads to various psychiatric symptoms, with depressive symptoms being among the most common. For patients with CI and comorbid depressive symptoms, the most common treatment involves the use of antidepressant medications. However, while depressive symptoms may improve, insomnia symptoms often persist.

Among non-pharmacological interventions aimed at promoting psychological well-being, Well-Being Therapy (WBT) stands out as a brief and innovative psychotherapeutic approach. WBT is a structured, manualized, short-term therapy that incorporates self-monitoring of well-being episodes through the use of a diary, cognitive restructuring of interfering thoughts and behaviors, and homework assignments.

Previous research has demonstrated the effectiveness of WBT in alleviating stress in populations experiencing 'allostatic load.' This study seeks to evaluate the therapeutic effects of six WBT sessions on individuals with CI and comorbid depressive symptoms.

Enrollment

84 estimated patients

Sex

All

Ages

8+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Diagnosed with Insomnia Disorder according to DSM-5 criteria, with a duration of at least 3 months.
  2. Pittsburgh Sleep Quality Index (PSQI) total score > 5.
  3. Age 8 years or older.
  4. Educational level of at least junior high school.
  5. Voluntarily agree to participate and provide written informed consent.
  6. Presence of depressive symptoms, defined as Hamilton Depression Scale (HAMD) score ≥ 16.

Exclusion criteria

  1. Presence of severe physical illnesses or major psychiatric disorders, or at risk of suicide.
  2. Diagnosed or suspected of having sleep breathing disorders, restless legs syndrome, circadian rhythm sleep disorders, or engaged in shift work.
  3. Pregnant or breastfeeding women.
  4. Currently undergoing any psychological therapy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

84 participants in 2 patient groups

WBT-CI
Experimental group
Treatment:
Behavioral: Well-Being Therapy
SHE-CI
Active Comparator group
Treatment:
Behavioral: Sleep Hygiene Education

Trial contacts and locations

1

Loading...

Central trial contact

Hongxing Wang, MD & PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems